Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Progress in adult ALL: incorporation of new agents to frontline treatment.
Treatment and outcomes of fingertip injuries at a large metropolitan public hospital.
Risk Factors for Recurrent Hematoma After Surgery for Acute Traumatic Subdural Hematoma.
Results of Cancer and Leukemia Group B 10102 (Alliance), a Phase 1/2 Study.
Should immunologic strategies be incorporated into frontline ALL therapy?
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Should immunologic strategies be incorporated into frontline ALL therapy?
Should immunologic strategies be incorporated into frontline ALL therapy? Best Pract Res Clin Haematol. 2018 12; 31(4):367-372.
View in:
PubMed
subject areas
Antibodies, Bispecific
Antibodies, Monoclonal, Humanized
Antigens, CD
Disease-Free Survival
Humans
Immunotherapy
Neoplasm Proteins
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Rituximab
authors with profiles
Wendy Stock